Kapur Rick
Sanquin Research, Department of Experimental Immunohematology, Amsterdam and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Br J Haematol. 2023 Mar;200(6):689-690. doi: 10.1111/bjh.18555. Epub 2022 Nov 14.
Kawasaki disease (KD) is an acute vasculitis of early childhood with unknown cause, which can be complicated by coronary artery lesions resulting in thrombosis. Fu and coworkers identify thymic stromal lymphopoietin (TSLP) to be increased in KD patients with thrombosis. They demonstrate that TSLP can activate platelets, induce mitophagy and trigger thrombus formation in vitro, suggesting that TSLP may have potential as a therapeutic target against KD-associated thrombosis. Commentary on: Fu L, et al. TSLP induces platelet mitophagy and promotes thrombosis in Kawasaki disease. Br J Haematol. 2023; 200:776-791.
川崎病(KD)是一种病因不明的幼儿急性血管炎,可并发冠状动脉病变导致血栓形成。傅及其同事发现,血栓形成的KD患者体内胸腺基质淋巴细胞生成素(TSLP)水平升高。他们证明,TSLP可在体外激活血小板、诱导线粒体自噬并触发血栓形成,这表明TSLP可能具有作为抗KD相关血栓形成治疗靶点的潜力。评论文章:傅L等人。TSLP诱导血小板线粒体自噬并促进川崎病血栓形成。《英国血液学杂志》。2023年;200:776 - 791。